Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Share this content:
Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men
Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

MONDAY, April 23, 2018 (HealthDay News) -- Flexible sigmoidoscopy screening is associated with reduced colorectal cancer (CRC) incidence and mortality in men, but not women, according to a study published online April 24 in the Annals of Internal Medicine.

Øyvind Holme, M.D., Ph.D., from Sørlandet Hospital Kristiansand in Norway, and colleagues conducted a randomized controlled trial involving adults aged 50 to 64 years at baseline without prior CRC. Participants underwent flexible sigmoidoscopy screening between 1999 and 2001 with and without additional fecal blood testing (20,552 patients) versus no screening (78,126 patients).

The adherence rates were 64.7 and 61.4 percent in women and men, respectively. Participants were followed for a median of 14.8 years. The researchers found that the absolute risks for CRC were 1.86 and 2.05 percent in the screening and control groups, respectively, among women (hazard ratio, 0.92; 95 percent confidence interval, 0.79 to 1.07). The corresponding risks were 1.72 and 2.50 percent in men (hazard ratio, 0.66; 95 percent confidence interval, 0.57 to 0.78). In women, the absolute risks for death from CRC were 0.60 and 0.59 percent in the screening and control groups, respectively (hazard ratio, 1.01; 95 percent confidence interval, 0.77 to 1.33). For men, the corresponding risks were 0.49 and 0.81 percent (hazard ratio, 0.63; 95 percent confidence interval, 0.47 to 0.83).

"Offering sigmoidoscopy screening in Norway reduced CRC incidence and mortality in men but had little or no effect in women," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »